(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:736261 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of FZD1 mRNA CTD PMID:22079256 (S)-colchicine decreases expression ISO RGD:736261 6480464 Colchicine results in decreased expression of FZD1 mRNA CTD PMID:24211769 1,1-dichloroethene decreases expression ISO RGD:62209 6480464 vinylidene chloride results in decreased expression of FZD1 mRNA CTD PMID:26682919 1,2-dimethylhydrazine multiple interactions ISO RGD:62209 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FZD1 mRNA CTD PMID:22206623 1,2-dimethylhydrazine decreases expression ISO RGD:62209 6480464 1, 2-Dimethylhydrazine results in decreased expression of FZD1 mRNA CTD PMID:22206623 1-naphthyl isothiocyanate decreases expression EXP 6480464 1-Naphthylisothiocyanate results in decreased expression of FZD1 mRNA CTD PMID:30723492 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of FZD1 mRNA CTD PMID:12075121 , PMID:17351261 17beta-estradiol increases expression ISO RGD:62209 6480464 Estradiol results in increased expression of FZD1 mRNA CTD PMID:25210133 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:736261 6480464 Dihydrotestosterone results in increased expression of FZD1 mRNA CTD PMID:29581250 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:736261 6480464 2 more ... CTD PMID:19095052 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:62209 6480464 Tetrachlorodibenzodioxin results in increased expression of FZD1 mRNA CTD PMID:15667827 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of FZD1 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of FZD1 mRNA CTD PMID:21215274 , PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of FZD1 mRNA CTD PMID:22298810 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of FZD1 mRNA CTD PMID:21346803 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:62209 6480464 tetrabromobisphenol A results in decreased expression of FZD1 mRNA CTD PMID:25172293 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:736261 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of FZD1 mRNA more ... CTD PMID:28628672 4,4'-sulfonyldiphenol multiple interactions ISO RGD:736261 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of FZD1 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol affects methylation ISO RGD:62209 6480464 bis(4-hydroxyphenyl)sulfone affects the methylation of FZD1 gene CTD PMID:31683443 4,4'-sulfonyldiphenol increases expression ISO RGD:62209 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of FZD1 mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide decreases expression ISO RGD:62209 6480464 Fenretinide results in decreased expression of FZD1 mRNA CTD PMID:16467112 5-aza-2'-deoxycytidine increases expression ISO RGD:62209 6480464 Decitabine results in increased expression of FZD1 mRNA CTD PMID:27915011 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of FZD1 mRNA CTD PMID:24780913 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of FZD1 mRNA CTD PMID:25825206 adenine decreases expression ISO RGD:736261 6480464 Adenine results in decreased expression of FZD1 mRNA CTD PMID:24211769 all-trans-retinoic acid increases expression ISO RGD:736261 6480464 Tretinoin results in increased expression of FZD1 mRNA CTD PMID:23724009 all-trans-retinoic acid decreases expression ISO RGD:736261 6480464 Tretinoin results in decreased expression of FZD1 mRNA CTD PMID:33167477 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of FZD1 mRNA CTD PMID:16483693 antimycin A decreases expression ISO RGD:736261 6480464 Antimycin A results in decreased expression of FZD1 mRNA CTD PMID:33512557 arsenite(3-) multiple interactions ISO RGD:62209 6480464 [arsenite co-treated with Benzo(a)pyrene] results in decreased expression of FZD1 mRNA CTD PMID:15894712 arsenite(3-) increases methylation ISO RGD:736261 6480464 arsenite results in increased methylation of FZD1 promoter CTD PMID:23974009 arsenite(3-) decreases expression ISO RGD:62209 6480464 arsenite results in decreased expression of FZD1 mRNA CTD PMID:15894712 , PMID:33053406 arsenous acid decreases expression ISO RGD:736261 6480464 Arsenic Trioxide results in decreased expression of FZD1 mRNA CTD PMID:20458559 benzo[a]pyrene multiple interactions ISO RGD:62209 6480464 [arsenite co-treated with Benzo(a)pyrene] results in decreased expression of FZD1 mRNA CTD PMID:15894712 benzo[a]pyrene increases methylation ISO RGD:736261 6480464 Benzo(a)pyrene results in increased methylation of FZD1 exon CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:736261 6480464 Benzo(a)pyrene results in decreased expression of FZD1 mRNA CTD PMID:26238291 benzo[a]pyrene decreases expression ISO RGD:62209 6480464 Benzo(a)pyrene results in decreased expression of FZD1 mRNA CTD PMID:15894712 benzo[a]pyrene diol epoxide I increases expression ISO RGD:736261 6480464 7 more ... CTD PMID:19150397 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of FZD1 mRNA CTD PMID:12075121 bisphenol A increases expression ISO RGD:62209 6480464 bisphenol A results in increased expression of FZD1 mRNA CTD PMID:32156529 , PMID:32370801 bisphenol A multiple interactions ISO RGD:736261 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FZD1 mRNA CTD PMID:28628672 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of FZD1 mRNA CTD PMID:25181051 bisphenol F multiple interactions ISO RGD:736261 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FZD1 mRNA CTD PMID:28628672 cadmium dichloride increases expression ISO RGD:62209 6480464 Cadmium Chloride results in increased expression of FZD1 mRNA CTD PMID:20478370 calcitriol increases expression ISO RGD:736261 6480464 Calcitriol results in increased expression of FZD1 mRNA CTD PMID:16002434 camptothecin decreases methylation ISO RGD:736261 6480464 Camptothecin results in decreased methylation of FZD1 gene CTD PMID:30720231 carbon nanotube increases expression ISO RGD:62209 6480464 Nanotubes, Carbon results in increased expression of FZD1 mRNA CTD PMID:25554681 chlorpyrifos affects expression EXP 6480464 Chlorpyrifos affects the expression of FZD1 mRNA CTD PMID:18502319 choline multiple interactions ISO RGD:62209 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of FZD1, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of FZD1 gene CTD PMID:20938992 cisplatin decreases expression ISO RGD:736261 6480464 Cisplatin results in decreased expression of FZD1 mRNA CTD PMID:24211769 cisplatin increases expression ISO RGD:736261 6480464 Cisplatin results in increased expression of FZD1 mRNA CTD PMID:27594783 copper atom increases expression EXP 6480464 Copper results in increased expression of FZD1 mRNA CTD PMID:30556269 copper atom multiple interactions ISO RGD:736261 6480464 [Chelating Agents binds to Copper] which affects the expression of FZD1 mRNA CTD PMID:30911355 copper(0) increases expression EXP 6480464 Copper results in increased expression of FZD1 mRNA CTD PMID:30556269 copper(0) multiple interactions ISO RGD:736261 6480464 [Chelating Agents binds to Copper] which affects the expression of FZD1 mRNA CTD PMID:30911355 curcumin decreases expression ISO RGD:736261 6480464 Curcumin results in decreased expression of FZD1 mRNA CTD PMID:15713895 cyclosporin A decreases expression ISO RGD:736261 6480464 Cyclosporine results in decreased expression of FZD1 mRNA CTD PMID:25562108 dexamethasone multiple interactions ISO RGD:736261 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of FZD1 mRNA more ... CTD PMID:28628672 dextran sulfate multiple interactions ISO RGD:62209 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FZD1 mRNA CTD PMID:29950665 diarsenic trioxide decreases expression ISO RGD:736261 6480464 Arsenic Trioxide results in decreased expression of FZD1 mRNA CTD PMID:20458559 diazinon affects expression EXP 6480464 Diazinon affects the expression of FZD1 mRNA CTD PMID:19130878 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of FZD1 mRNA CTD PMID:21266533 dieldrin increases expression EXP 6480464 Dieldrin results in increased expression of FZD1 mRNA CTD PMID:19130878 disodium selenite multiple interactions ISO RGD:62209 6480464 [ptaquiloside co-treated with Sodium Selenite] results in decreased expression of FZD1 mRNA CTD PMID:23274088 disodium selenite decreases expression ISO RGD:62209 6480464 Sodium Selenite results in decreased expression of FZD1 mRNA CTD PMID:23274088 dorsomorphin multiple interactions ISO RGD:736261 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FZD1 mRNA CTD PMID:27188386 ethanol increases expression ISO RGD:62209 6480464 Ethanol results in increased expression of FZD1 mRNA CTD PMID:30319688 ethosuximide increases expression EXP 6480464 Ethosuximide results in increased expression of FZD1 mRNA CTD PMID:26420483 ethosuximide multiple interactions EXP 6480464 Ethosuximide inhibits the reaction [APP protein modified form results in decreased expression of FZD1 mRNA] CTD PMID:26420483 ethyl methanesulfonate decreases expression ISO RGD:736261 6480464 Ethyl Methanesulfonate results in decreased expression of FZD1 mRNA CTD PMID:24211769 etoposide decreases expression ISO RGD:736261 6480464 Etoposide results in decreased expression of FZD1 mRNA CTD PMID:24211769 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of FZD1 mRNA CTD PMID:24136188 folic acid multiple interactions ISO RGD:62209 6480464 [1 more ... CTD PMID:20938992 , PMID:22206623 furan decreases expression EXP 6480464 furan results in decreased expression of FZD1 mRNA CTD PMID:25539665 genistein decreases expression EXP 6480464 Genistein results in decreased expression of FZD1 mRNA CTD PMID:12075121 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of FZD1 mRNA CTD PMID:33387578 hydroxyurea decreases expression ISO RGD:736261 6480464 Hydroxyurea results in decreased expression of FZD1 mRNA CTD PMID:24211769 indometacin multiple interactions ISO RGD:736261 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of FZD1 mRNA more ... CTD PMID:28628672 L-methionine multiple interactions ISO RGD:62209 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of FZD1, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of FZD1 gene CTD PMID:20938992 lipopolysaccharide multiple interactions ISO RGD:736261 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of FZD1 mRNA CTD PMID:35811015 methyl methanesulfonate decreases expression ISO RGD:736261 6480464 Methyl Methanesulfonate results in decreased expression of FZD1 mRNA CTD PMID:24211769 methylmercury chloride decreases expression ISO RGD:736261 6480464 methylmercuric chloride results in decreased expression of FZD1 mRNA CTD PMID:28001369 mitomycin C decreases expression ISO RGD:736261 6480464 Mitomycin results in decreased expression of FZD1 mRNA CTD PMID:24211769 N-methyl-4-phenylpyridinium decreases expression ISO RGD:736261 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of FZD1 mRNA CTD PMID:24810058 nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of FZD1 mRNA CTD PMID:24136188 nickel atom affects expression EXP 6480464 Nickel affects the expression of FZD1 mRNA CTD PMID:19130878 nickel atom decreases expression ISO RGD:736261 6480464 Nickel results in decreased expression of FZD1 mRNA CTD PMID:25583101 niclosamide affects localization ISO RGD:736261 6480464 Niclosamide affects the localization of FZD1 protein CTD PMID:19772353 nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of FZD1 mRNA CTD PMID:33484710 ozone increases expression EXP 6480464 Ozone results in increased expression of FZD1 mRNA CTD PMID:33146391 paracetamol increases expression ISO RGD:736261 6480464 Acetaminophen results in increased expression of FZD1 mRNA CTD PMID:29067470 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of FZD1 mRNA CTD PMID:26887261 paraquat decreases expression ISO RGD:62209 6480464 Paraquat results in decreased expression of FZD1 mRNA, Paraquat results in decreased expression of FZD1 protein CTD PMID:30171970 paraquat multiple interactions ISO RGD:736261 6480464 WNT1 protein inhibits the reaction [Paraquat results in decreased expression of FZD1 mRNA] CTD PMID:30171970 perfluorononanoic acid decreases expression ISO RGD:736261 6480464 perfluoro-n-nonanoic acid results in decreased expression of FZD1 mRNA CTD PMID:32588087 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of FZD1 mRNA CTD PMID:19162173 potassium chromate multiple interactions ISO RGD:736261 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of FZD1 mRNA CTD PMID:22079256 potassium chromate increases expression ISO RGD:736261 6480464 potassium chromate(VI) results in increased expression of FZD1 mRNA CTD PMID:22079256 Ptaquiloside multiple interactions ISO RGD:62209 6480464 [ptaquiloside co-treated with Sodium Selenite] results in decreased expression of FZD1 mRNA CTD PMID:23274088 pyrimidifen decreases expression ISO RGD:736261 6480464 pyrimidifen results in decreased expression of FZD1 mRNA CTD PMID:33512557 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of FZD1 mRNA CTD PMID:19013527 rotenone decreases expression ISO RGD:736261 6480464 Rotenone results in decreased expression of FZD1 mRNA CTD PMID:33512557 rotenone affects expression EXP 6480464 Rotenone affects the expression of FZD1 mRNA CTD PMID:28374803 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:736261 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of FZD1 mRNA CTD PMID:35811015 SB 431542 multiple interactions ISO RGD:736261 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FZD1 mRNA CTD PMID:27188386 sodium arsenite increases expression ISO RGD:736261 6480464 sodium arsenite results in increased expression of FZD1 mRNA CTD PMID:28595984 sodium arsenite affects expression ISO RGD:736261 6480464 sodium arsenite affects the expression of FZD1 mRNA CTD PMID:34032870 sodium dichromate increases expression ISO RGD:62209 6480464 sodium bichromate results in increased expression of FZD1 mRNA CTD PMID:31558096 sunitinib increases expression ISO RGD:736261 6480464 Sunitinib results in increased expression of FZD1 mRNA CTD PMID:31533062 tert-butyl hydroperoxide decreases expression ISO RGD:736261 6480464 tert-Butylhydroperoxide results in decreased expression of FZD1 mRNA CTD PMID:29432895 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of FZD1 mRNA CTD PMID:23411599 , PMID:34492290 titanium dioxide multiple interactions ISO RGD:62209 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FZD1 mRNA CTD PMID:29950665 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of FZD1 mRNA CTD PMID:33387578 triclosan decreases expression ISO RGD:736261 6480464 Triclosan results in decreased expression of FZD1 mRNA CTD PMID:30510588 valproic acid increases expression ISO RGD:736261 6480464 Valproic Acid results in increased expression of FZD1 mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO RGD:736261 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FZD1 mRNA CTD PMID:27188386